Introduction
expression of Id genes is down-regulated upon differentiation in many cell types Hara et al., The basic-helix-loop-helix (bHLH) proteins are a family 1991; Sun et al., 1991; Kreider et al., 1992 ; Le Jossic of eukaryotic transcription factors that have been shown et al., 1994; Einarson and Chao, 1995) . Conversely, ectopic to play a key role in the differentiation of a number of cell expression of Id1 inhibits B-cell development (Sun, 1994) lineages, including muscle cells, B-and T-lymphocytes, and the differentiation of muscle (Jen et al., 1992) , myeloid pancreatic β cells, osteoblasts and neurons (reviewed in (Kreider et al., 1992) , erythroid (Shoji et al., 1994; Lister Jan and Jan, 1993; Weintraub, 1993; Olson and Klein, et al., 1995) and mammary epithelial cells (Desprez et al., 1994) . These proteins generally contain a helix- loop-1995) . Several lines of evidence also suggest that Id helix (HLH) dimerization domain, consisting of highly proteins play a role in the G 0 to S phase transition of the conserved amphipathic helices separated by a loop of cell cycle. Thus, the stimulation of quiescent fibroblasts variable length and sequence, and an adjacent DNAwith serum or growth factors induces the transcription of binding domain which is rich in basic amino acids (Murre Id1, Id2 and Id3 (Benezra et al., 1990; Christy et al., et al., 1989a,b; Davis et al., 1990; Ellenberger et al., 1991; Deed et al., 1993; Barone et al., 1994; Hara 1994; Ma et al., 1994) . There are two main categories of et al., 1994) ; inhibiting Id protein synthesis by antisense bHLH proteins. The so-called A class are ubiquitously oligonucleotides prevents the re-entry of arrested cells expressed proteins such as those encoded by differentially into the cell cycle Hara et al., 1994) ; spliced transcripts from the E2A (E12, E47 and E2-5/ and Id expression declines as senescent fibroblasts lose ITF1 proteins), E2-2/ITF2 and HEB/HTF4 genes (Murre their proliferative activity (Hara et al., 1994 ). et al., 1989b Henthorn et al., 1990; Zhang et al., 1991;  In mammalian cells, the G 0 to S phase transition is Hu et al., 1992; Skerjanc et al., 1996) whereas class B comprises tissue-specific bHLH proteins such as the MyoD orchestrated by a number of cyclin-dependent kinases (Cdks), including Cdk4 and Cdk6, acting in conjunction with their regulatory partners, cyclins D1, D2 and D3, and Cdk2 in conjunction with cyclins E and A (reviewed in Peters, 1994; Sherr, 1994; Weinberg, 1995) . The current view is that the cyclin D-dependent kinases are essential for passage through the restriction point in late G 1 , at which cells become committed to proceed with division irrespective of mitogenic stimuli, whereas cyclin E-Cdk2 activity is required for the initiation of S phase (Hatakeyama et al., 1994; Ohtsubo et al., 1995; Resnitzky and Reed, 1995) . There is therefore a great deal of interest in identifying specific substrates for these Cdk complexes. To date, the only known targets for the G 1 -specific Cdks are the retinoblastoma gene product (pRb) and its relatives, p107 and p130 (Dowdy et al., 1993; Ewen et al., 1993; Matsushime et al., 1994; Meyerson and Harlow, 1994; Beijersbergen et al., 1995) , which serve as negative regulators of heterodimeric transcription factor complexes containing members of the E2F and DP families (Lam and La Thangue, 1994; Weinberg, 1995) . Phosphorylation by Cdks appears to be critical for modulating the interactions between these proteins. Here, we establish a potential link between Cdk activity and bHLH transcription factor complexes by demonstrating that Id2 is a substrate for cyclin E-Cdk2 and cyclin A-Cdk2. Phosphorylation of a specific serine residue within a consensus Cdk target sequence prevents Id2 from interfering with the formation of E-box DNA-binding complexes in vitro. Moreover, in serum-stimulated human diploid fibroblasts, the phosphorylation of Id2 occurs at a time in late G 1 that correlates with activation of cyclin E-Cdk2 and with the formation of a specific DNA-binding complex that would otherwise be prevented by the excess of Id2. The data suggest that cell cycle-dependent modulation of bHLH activity may be achieved by regulating the abundance and phosphorylation status of Id proteins
Results

E-box DNA-binding complexes in serumstimulated human fibroblasts
The complementary effects of E2A and Id proteins on cell proliferation prompted us to ask whether the DNAbinding complexes formed on a typical E-box (CANNTG) varied during cell cycle progression. Human diploid Fig. 1 . Cell cycle-dependent expression of an E-box complex sensitive fibroblasts (TIG-3 cells) were rendered quiescent in to Id2. Quiescent TIG-3 cells were stimulated by the addition of serum medium containing 0.2% serum for 4 days and suband nuclear extracts or total cell lysates were prepared at the indicated times after serum addition. (A) The nuclear extracts were used in sequently induced to re-enter the cell cycle by addition of EMSA assays using a 26 bp oligonucleotide E-box probe from the 20% serum. Nuclear extracts were prepared at various muscle creatine kinase (MCK) promoter. The specific high molecular times after addition of serum and used in electrophoretic weight complex (arrowed) was competed by excess oligonucleotide mobility shift assays (EMSA) with an oligonucleotide (lane 9) but not by mutant oligonucleotide (lane 8). In lanes 10 and 11, 20 ng of bacterially expressed Id1 or Id2 were added to the probe from the muscle creatine kinase (MCK) enhancer.
reactions. (B) Samples (50 μl) of total cell lysate were fractionated by This oligonucleotide has been used extensively to charac-SDS-PAGE in a 12% acrylamide gel, transferred to nitrocellulose, and terize bHLH protein complexes in a variety of cell types immunoblotted with antisera against human E2A, Id2 or cyclin A as (Johnson et al., 1992; Kreider et al., 1992;  Einarson and indicated on the right. The immune complexes were detected by ECL. Chao, 1995) . A high molecular weight protein-DNA complex was observed whose abundance changed significantly during the progression from G 0 to S phase (Figure addition ( Figure 1A ). The specificity of the complex was confirmed by its sensitivity to competition by an excess 1A). Relatively low levels of this complex were formed with extracts from quiescent cells (lane 1) but it became of unlabelled oligonucleotide but not by an equivalent oligonucleotide containing a mutation in the E-box (Figure barely detectable after 4 h of serum stimulation (lane 2). However, the complex was re-established by 12 h and 1A, lanes 8 and 9). Moreover, the formation of this protein-DNA complex was inhibited by the addition of reached a maximum between 16 and 24 h after serum human cells. In all Id family members characterized thus far in different species, the HLH region is highly conserved (Box 2 in Figure 2 ). However, the sequences outside the HLH motif are distinct except for three regions that show some degree of homology, designated boxes 1, 3 and 4. In particular, box 1 contains a sequence, SPVR, that conforms to the consensus for phosphorylation by cyclindependent kinases. This motif is conserved in Id2, Id3 and Id4 but is not present in the Id1 protein, identifying a potential difference between Id1 and other family members.
To determine whether the Id proteins are indeed targets for phosphorylation by Cdks, human Id1 and Id2 were expressed in bacteria as fusion proteins with glutathione S-transferase (GST) and used as substrates in an in vitro vectors; previous studies (Kato et al., 1993; Meyerson depicted by the striped lines. The bold lines in Box 1 identify and Harlow, 1994; Parry et al., 1995) have shown that consensus sites for phosphorylation by Cdks that are present in Id2, Id3 and Id4, but not in Id1. The sequences in this figure are based on the cyclin-Cdk complexes generated in this system are the data in Biggs et al. (1992) , Deed et al. (1993) , Hara et al. (1994) capable of phosphorylating relevant substrates, such as and Pagliuca et al. (1995) .
pRb, as GST-linked fusion proteins. Several combinations were compared that were representative of the cyclin D-dependent kinases and of Cdk2 complexed to either 20 ng of human Id2 protein, expressed as a histidinetagged fusion protein in bacteria, although a similar cyclin E or cyclin A. GST-Id1, which lacks a consensus Cdk target, was not phosphorylated by any of the cyclinquantity of human Id1 protein had no effect ( Figure 1A , lanes 10 and 11).
Cdk complexes tested ( Figure 3A ). In contrast, GST-Id2 protein was clearly phosphorylated by Cdk2 in association The most obvious explanation for these results would be that the proteins that participate in the complex are with either cyclins E or A ( Figure 3B , lanes 7 and 8) but not by the cyclin D-dependent kinases Cdk4 and Cdk6 expressed at variable levels during the G 0 to S phase transition. However, the prototypic E-box-binding proteins ( Figure 3A , lanes 1-6). The activity of each kinase complex was confirmed by the phosphorylation of GSTencoded by the E2A gene did not show equivalent cell cycle fluctuations as judged by immunoblotting of cell Rb, which is a substrate for all of the cyclin-Cdk complexes tested and contains multiple Cdk consensus sites lysates with an E2A-specific antiserum ( Figure 1B ). In contrast, it has been previously established that Id gene ( Figure 3C and additional data not shown). The clear distinction between Id2 which has a single consensus expression is dramatically increased following serum stimulation of quiescent cells, with two distinct peaks in Cdk site and Id1 which does not, suggested that the phosphorylation of Id2 was a specific and potentially early G 1 and at the G 1 -S transition Hara et al., 1994) . The biphasic induction of Id2 in serumrelevant event. Moreover, the phosphorylation of both GST-Rb and GST-Id2 by cyclin E-Cdk2 was abolished stimulated TIG-3 cells is illustrated in Figure 1B . Thus, Id2 protein levels were extremely low in quiescent cells, by addition of the Cdk inhibitor p21 CDKN1 ( Figure 3C ), suggesting that it was attributable to a Cdk rather than to reached a maximum at about 2-4 h after serum addition and declined again by 8-12 h. This pattern of Id2 non-specific kinase activity in the insect cell lysates. expression in early G 1 is the inverse of that of the E-boxbinding complex in Figure 1A , suggesting that the level Effects of phosphorylation on Id2 activity in vitro To determine whether the phosphorylation of Id2 by Cdk2 of the complex might be dictated by the expression of Id2. However, the second peak of Id2 expression, which alters its activity, an electrophoretic mobility shift assay (EMSA) was established using the MCK E-box probe roughly parallels the induction of cyclin A in late G 1 and S phase ( Figure 1B ), coincides with maximum levels of and components expressed by coupled transcription and translation of plasmid DNAs. The sizes and yields of the the E-box complex.
various products were verified by SDS-PAGE (not shown).
A partial fragment of the E12 protein, ΔE12 (Staudinger Phosphorylation of Id2 in vitro by cyclin E-Cdk2 and cyclin A- Cdk2 et al., 1993) , which includes the bHLH region (residues 508-654) formed a complex on the 32 P-labelled DNA To try to reconcile these observations, we considered whether some of the relevant proteins might be subject to probe consistent with the formation of a ΔE12 homodimer ( Figure 4A , lane 2). A much weaker band shift was cell cycle-dependent phosphorylation, by analogy with components of the pRb/E2F system of transcriptional detected using MyoD alone ( Figure 4A , lane 3) consistent with its reduced ability to form homodimers as opposed regulators. It has been previously noted that some Id proteins contain consensus phosphorylation sites for a to heterodimers with other HLH proteins. A 1:1 mixture of ΔE12 and MyoD proteins produced an additional DNAvariety of kinases, including the cyclin-dependent kinases (Nagata et al., 1995) . Figure 2 shows an amino acid binding complex, presumably a heterodimer, that migrated at an intermediate position between the ΔE12-ΔE12 and sequence alignment for the four Id genes identified in 1 ng of recombinant Id1 protein was enough to inhibit the formation of a ΔE12-MyoD-DNA complex ( Figure  4B , lanes 3 and 4) whereas 5-to 10-fold more Id2 protein (~5 ng) was required to obtain the same effect on the heterodimer ( Figure 4B , lane 11). In contrast, the addition of between 10 and 20 ng of Id2 protein was able to inhibit the formation of the homodimer ΔE12-ΔE12-DNA complex ( Figure 4B , lanes 12 and 13) whereas disruption of the homodimer complex was not observed with Id1 protein (lane 7). These results indicate a hitherto unrecognized difference in the specificity of Id1 and Id2 for binding to bHLH proteins.
Similar competition assays were then performed using preparations of Id1 and Id2 that had been pretreated with Sf9 cell lysates containing active cyclin A-Cdk2 and unlabelled ATP ( Figure 4C , lanes 6 and 10) or incubated with uninfected Sf9 cell lysates ( Figure 4C , lanes 3-5 and 7-9). Increasing amounts of the Id1 and Id2 proteins that had been treated with uninfected Sf9 cell lysates inhibited the formation of ΔE12-MyoD-DNA complexes as before (lanes 3-5 and 7-9) whereas addition of 10 ng of an unrelated histidine-tagged protein, in this case p16 CDKN2a , had no effect (lane 2). Predictably, incubation of Id1 with cyclin A-Cdk2 made no discernible difference to its activity in this assay, since Id1 lacks the relevant Cdk target site ( Figure 4C , lane 6). However, incubation of Id2 with cyclin A-Cdk2 completely abolished its ability to disrupt the ΔE12-ΔE12 and ΔE12-MyoD DNA-binding complexes, even with 10 ng of protein ( Figure 4C , lane 10). These data imply that Id2 is inactivated by phosphorylation by cyclin A-Cdk2.
Identification of the Cdk2 phosphorylation site in Id2
As shown in Figure 2 , there is a potential phosphorylation Cdk2 target, a mutant form of Id2 was generated (desigin the presence or absence of the Cdk-inhibitor p21 CDKN1 expressed as nated Id2-S5A) in which the relevant serine was changed a histidine-tagged fusion protein in bacteria.
to alanine. The Id2-S5A mutant was not detectably phosphorylated by cyclin A-Cdk2 in vitro ( Figure 5A ). In addition, bacterially produced Id2-S5A protein remained MyoD-MyoD homodimer complexes ( Figure 4A , lane 4). As controls for the specificity of these interactions, an capable of inhibiting the formation of a ΔE12-MyoD-DNA complex both before ( Figure 5B , lane 2) and after excess of unlabelled oligonucleotide completely abolished the formation of complexes on the labelled probe whereas treatment with cyclin A-Cdk2 ( Figure 5B , lane 3). This contrasts with the behaviour of the wild-type Id2 protein an oligonucleotide containing a mutated E-box sequence did not ( Figure 4A , lanes 5 and 6). Moreover, addition in the same assay ( Figure 5B , lanes 4 and 5). These data suggest that phosphorylation of Ser5 is important for the of a polyclonal antiserum against MyoD decreased the mobility of the MyoD-MyoD complexes ( Figure 4A , regulation of Id2 activity. lanes 7 and 8) as well as affecting the mobility of the presumed ΔE12-MyoD heterodimer ( Figure 4A, lanes 9 Phosphorylation of Id2 during G 0 to S phase progression and 10). A higher concentration of antibody (2 μl) was required to shift the heterodimer whereas the ΔE12-To determine whether an analogous phosphorylation of Id2 occurs in vivo, quiescent TIG-3 human diploid ΔE12 homodimer complex was unaffected by the MyoD antiserum.
fibroblasts were induced to re-enter the cell cycle by addition of serum and at various times thereafter the cells Having validated the mobility shift assay, we next asked whether the addition of Id proteins could interfere with were incubated with 32 P-labelled orthophosphate for 2 h and immunoprecipitated with a polyclonal antiserum the formation of complexes containing ΔE12-ΔE12 homodimers or ΔE12-MyoD heterodimers. Approximately 0.5-against Id2. As shown in Figure 6A , the Id2 protein became 32 P-labelled at~12 h following serum addition and continued to be phosphorylated at subsequent time points up to 24 h. Flow cytometric analysis of parallel cell cultures indicated that the cells began to enter S phase after~16 h. The timing of this phosphorylation would be more consistent with the action of cyclin E-Cdk2 than cyclin A-Cdk2 (Dulic et al., 1992; Koff et al., 1992) . To address this issue, equivalent cultures of unlabelled TIG-3 cells were precipitated with antisera against either cyclin E or cyclin A and the associated kinase activities assayed on histone H1 as substrate ( Figure 6B ). The cyclin E-dependent H1-kinase activity was first detectable at 12 h after serum addition, correlating well with the first appearance of phosphate label in Id2. In contrast, the most significant increase in cyclin A-dependent H1-kinase activity did not begin until between 18 and 24 h after serum stimulation. However, these data do not exclude a contribution from both complexes.
It was also important to determine whether this in vivo phosphorylation of Id2 protein occurred on the same site or sites as the in vitro phosphorylation by cyclin-Cdk complexes. The 32 P-labelled Id2 bands from metabolically labelled cells were therefore fractionated by SDS-PAGE, recovered from the gels and subjected to two-dimensional tryptic peptide mapping (Boyle et al., 1991) . Similar maps were prepared using histidine-tagged Id2 protein that had been phosphorylated in Sf9 cell lysates by cyclin A-Cdk2. A single tryptic phosphopeptide was observed in Id2 that had been phosphorylated in vitro, whereas two phosphopeptides were observed in the Id2 recovered from labelled cells ( Figure 7A and B) . In a mixing experiment, it was confirmed that the tryptic peptide labelled in vitro by cyclin A-Cdk2 co-migrated with one of the peptides labelled in vivo (indicated by the arrow in Figure 7C ). These results indicated that the Id2 protein is phosphorylated on Ser5 in vivo. The identity of the other phosphopeptide is presently unclear but it presumably reflects the action of a non-Cdk kinase. For example, there is a report that Id2 can be phosphorylated by PKA or PKC in vitro, but that neither phosphorylation affects the activity of Id2 (Nagata et al., 1995) . In our experiments, both Id2 peptides became phosphate-labelled by 12 h after serum addition and the ratios of the two spots remained essentially constant at subsequent time points (not shown). However, the data do not exclude some fluctuation in the immunoprecipitated with antiserum against human cyclin E or cyclin levels of E-box-binding proteins other than E2A and do A and the level of associated kinase activity was assayed using histone not address the relative abundance of the bHLH and Id2 H1 as a substrate. The phosphorylated products were analysed by SDS-PAGE, detected by autoradiography, and quantitated by proteins. To examine these issues and to obtain further phosphorimaging. support for the model, mobility shift assays were performed using mixtures of nuclear extracts prepared from TIG-3 cells at either 4 or 16 h after addition of serum.
Modulation of Id2 activity by phosphorylation in
effect on the potency of the 4 h extract. Since the amount of Id2 expressed in late G 1 is equivalent to that in the 4 The former should contain predominantly unphosphorylated Id2 while the latter should contain essentially the h sample, there would clearly be enough to block the formation of E-box complexes unless the vast majority of same amount of Id2 protein (see Figure 1B ) that has been phosphorylated on Ser5. As shown previously, the 4 h it was prevented from doing so by phosphorylation. We suggest, therefore, that the fluctuations in the E-box extract did not support the formation of a DNA-binding complex whereas the 16 h extract did (Figure 8 , lanes 1 complex observed in serum-stimulated TIG-3 cells reflect both the level and phosphorylation status of Id2 and that and 2). Significantly, a 1:1 mixture of the two extracts did not give a detectable complex (lane 3) suggesting that the the reappearance of this complex in late G 1 coincides with the phosphorylation of Id2 by cyclin E-Cdk2. amount of free unphosphorylated Id2 in the 4 h extract was able to compete with all of the available bHLH proteins in the 16 h extract. Decreasing the proportion of
Inhibition of cell growth by unphosphorylated Id2
Since it has been previously suggested that elevated 4 h extract only marginally restored the formation of the E-box complex (lanes 4 and 5). More substantial restoraexpression of Id2 stimulates cell growth (Iavarone et al., 1994; Lasorella et al., 1996) , we were interested in tion of the complex was achieved by partially depleting the unphosphorylated Id2 in the 4 h extract by immunodetermining whether the S5A mutant behaved differently. The wild-type and S5A cDNAs were therefore transferred precipitation (lane 6). As predicted, a similar immunodepletion experiment with antiserum against Id1 had no into the eukaryotic expression vector pcDNA3 (which Electrophoretic mobility shift assays were performed using nuclear extracts prepared from TIG-3 cells at 4 h or 16 h after serum addition (as in Figure 1A ). Each reaction contained a total of 5 μl of nuclear extract. In lanes 3, 4 and 5, the 4 h and 16 h extracts were mixed in 1:1, 1:2 and 1:3 ratios respectively (shown as percentage contributions Fig. 7 . Tryptic peptide mapping of phosphorylated Id2. 32 P-labelled above each lane). In lanes 6 and 7, the 4 h extract was pre-cleared by Id2 protein phosphorylated in vitro using cyclin A-Cdk2 produced in immunoprecipitation with an antiserum against either Id2 or Id1, as Sf9 cells (A) or immunoprecipitated from metabolically labelled TIG-3 indicated. cells (B), was subjected to two-dimensional tryptic peptide mapping. The first dimension was electrophoresis (from left to right) and the second dimension chromatography (bottom to top), with the origin Consistent results were obtained in several experiments and with both NIH 3T3 and U2OS cells (Table I) . Although the interpretation of these data is complicated by the the expense of differentiation whereas overexpression of bHLH proteins is associated with cell cycle arrest presence of endogenous Id2, they clearly imply that the non-phosphorylatable form of Id2 is growth inhibitory. (Crescenzi et al., 1990; Sorrentino et al., 1990; Jen et al., 1992; Kreider et al., 1992; Deed et al., 1993; Gu et al. , Thus, phosphorylation of Id2 may be required for cells to progress from G 1 into S. 1993; Iavarone et al., 1994; Peverali et al., 1994; Desprez et al., 1995) . More specifically, the expression of Id genes is markedly and rapidly increased when quiescent cells
Discussion
are stimulated with serum growth factors Christy et al., 1991; Barone et al., 1994 ; Hara et al., There are a number of reasons to suspect a link between Id function and cell cycle progression. In general terms, 1994) whereas abrogation of Id expression using antisense oligonucleotides prevents G 1 progression (Barone et al., ectopic expression of Id favours cell proliferation at 1994; Hara et al., 1994) . Since the Id proteins act by containing the Cdk2 site. The location of this second phosphorylation site and its possible significance are not forming inactive heterodimers with bHLH transcription factors, we were interested in determining whether cell yet clear. In contrast, we showed that Cdk2 phosphorylation occurs on Ser5 (Figure 5 ), within an obvious cycle variations in Id expression were reflected in the types and levels of DNA-binding complexes formed by consensus for Cdk phosphorylation, SPVR, that is common to Id2, Id3 and Id4 (see Figure 2) . We also demonstrated the bHLH proteins.
We chose to examine this issue in human diploid unequivocally that phosphorylation of Ser5 by Cdk2 negates the ability of Id2 to disrupt ΔE12 homodimer and fibroblasts, which are known to express both Id1 and Id2 as well as E2A-related products, and which respond ΔE12-MyoD heterodimer complexes on DNA (Figure 4 ) whereas the S5A mutant of Id2 remained effective even predictably in classical serum depletion and addition experiments (Hara et al., 1994) . Nuclear extracts from after exposure to active cyclin A-Cdk2 ( Figure 5) . Thus, the high levels of both the DNA-binding complex and Id2 these cells contain proteins that form a distinct DNAbinding complex on a standard E-box oligonucleotide can be readily reconciled if the Id2 protein expressed in late G 1 is quantitatively inactivated by phosphorylation from the MCK promoter ( Figure 1A) . However, we are not certain of the identity of the bHLH proteins in this by cyclin E-Cdk2. If this is indeed the case, then what purpose would be complex since it was only partially sensitive to E2A antiserum (not shown). Interestingly, the complex was served by the second peak of Id2 expression in late G 1 ? One possibility is that the phosphorylation of Id2 by cyclin sensitive to competition by Id2 but not Id1 ( Figure 1A) , indicating a clear difference in the specificity of the Id E-Cdk2 kinase does not inactivate Id2 but changes its binding specificity. Thus, while E2A-like bHLH proteins family members. A similar difference was apparent in the in vitro EMSA assays in that Id2 was much more effective may be the main targets of Id2 in early G 1 phase, the Cdk2-phosphorylated form of Id2 that prevails in late G 1 than Id1 at disrupting ΔE12 homodimers ( Figure 4A and B), as also noted by Nagata et al. (1995) . Conversely, Id1 might bind to some other protein that is important for regulating the G 1 to S transition. Perhaps the most attractive was more effective than Id2 at disrupting the formation of ΔE12-MyoD heterodimers. Analogous results were candidate would be pRb as it has been reported that pRb binds to Id2, but not to Id1 or Id3 (Iavarone et al., 1994 ; obtained using the full-length E12 protein although the resultant homodimer appeared to bind DNA less effect- Lasorella et al., 1996) . However, we have been unable to confirm this interaction by co-precipitation from cell ively than the ΔE12 homodimer (not shown). A previous report suggested that a domain adjacent to the bHLH lysates, by binding in vitro, or by testing the components in a yeast two-hybrid assay (not shown). Another candidate region in E12 inhibits the DNA-binding capacity of the E12 homodimer (Sun et al., 1991) . However, the ΔE12 could be the recently identified MIDA1 protein, which lacks a canonical HLH motif yet was isolated via its protein used in the present study (residues 508-654) and another derivative of E12, encompassing amino acids interaction with Id . To try to address the biological significance of the 490-654, were both found to bind efficiently to DNA in this system despite the presence of the putative inhibitory phosphorylation, we transfected cells with vectors expressing Id2 and the non-phosphorylatable S5A, in the domain (Figure 4 and additional data not shown).
Irrespective of its composition, a striking feature of the expectation that Id2 might promote cell growth (Iavarone et al., 1994; Lasorella et al., 1996) . In our hands, Id2 E-box complex observed in Figure 1 was its fluctuation during the G 0 to S phase progression. The level of the alone had no effect on the colony-forming efficiency of either NIH 3T3 or U2OS cells (Table I ) and did not complex declined markedly upon serum stimulation, with a nadir at~4 h, but then recovered at~8-12 h. This significantly change the cell cycle profile of transiently transfected U2OS cells (not shown). In hindsight, this is pattern was an almost exact mirror image of the initial peak of Id2 expression, suggesting that the induction of not particularly surprising given that both the exogenous and endogenous Id2 in these cells will presumably be Id2 was preventing the formation of the complex. The mixing experiments described in Figure 8 would be subject to phosphorylation by Cdk2. However, expression of Id2-S5A caused an~50% reduction in colony formation, consistent with this interpretation as Id2 appeared to be in considerable excess over the bHLH proteins at the 4 h suggesting that the continued presence of non-phosphorylated Id2 is growth inhibitory. The simplest interpretation time point. A stoichiometric excess of Id proteins over the E-proteins has been noted in other cell systems (Jen would be that Id2 has to be phosphorylated in order for cells to progress through the cycle, but this is a complex et al., 1992) . However, the data in Figure 1 presented an obvious paradox in that the maximum levels of the E-box issue that requires further investigation. Many other questions remain unresolved. Perhaps the complex occurred at 16-24 h, at a time when Id2 expression was also maximal. most pressing is the identity of the E-box-binding proteins observed in serum-stimulated fibroblasts and experiments The resolution of this paradox rests in the phosphorylation of Id2 that takes place in late G 1 (Figure 6 ). Tryptic are underway to try to characterize these components. Since the complex is sensitive to Id2 but not to Id1, it is peptide mapping confirmed that at least part of this phosphorylation occurs on a peptide that is a target for interesting to consider whether fibroblasts contain additional bHLH proteins, perhaps binding to distinct E-box Cdk2 in vitro (Figure 7 ) and its timing would be consistent with the activation of cyclin E-Cdk2 (Figure 6 and Dulic elements, that are regulated by Id1. Because Id1 lacks the Cdk consensus site, it may not be inactivated in late G 1 et al., 1992; Koff et al., 1992) . Curiously, the second tryptic phosphopeptide in metabolically labelled Id2 also despite showing the same biphasic pattern of expression as Id2. On the basis of the SPVR site, it seems likely that showed cell cycle dependence, appearing at roughly the same time as (perhaps marginally before) the peptide Id3 and Id4 might be subject to the same regulatory controls as Id2 and indeed Nagata et al. showed that annealed and labelled with [α-32 P]dCTP using the Klenow fragment of rat Id3 could be phosphorylated in vitro by a purified E.coli DNA polymerase. Two equivalent oligonucleotides containing a preparation of cdc2 (Nagata et al., 1995 (Nagata et al., 1995) . It is therefore intriguing that double-stranded probe. The mixtures were pre-incubated without the phosphorylation close to the amino-terminus of Id2 has labelled probe, at room temperature for 10 min, and for a further 15 min at room temperature after addition of the labelled probe. The binding such a profound effect on binding via the HLH domain, reactions were then subjected to electrophoresis in a 6% polyacrylamide perhaps indicating that this domain (box 1 in Figure 2) gel in 25 mM Tris base, 25 mM boric acid and 0.5 mM EDTA (0.5ϫ either participates in or contributes to the interactions with TBE) at 150 V for 2 h at room temperature. The gels were dried and E-proteins. that are unable to bind to DNA. Nevertheless, in both
In some experiments, the Sf9 cell lysates were preincubated for 10 min cases, the action of cyclin-dependent kinases will directly at 30°C with 20 ng of histidine-tagged p21 CDKN1 protein.
influence the patterns of gene expression during the cell cycle. The pressing challenge is to identify genes relevant
Immunoblot analysis
to the G 0 to S phase transition that are either positively
Total cell lysates were fractionated by SDS-PAGE in a 12% gel according to standard protocols, and proteins were transferred to nitrocellulose or negatively regulated by Id-sensitive transcription factor filters as described previously (Bates et al., 1994; Parry et al., 1995) .
complexes.
Id2 and cyclin A were detected with the SC-489 rabbit polyclonal antibody (Santa Cruz) or with the E23 mouse monoclonal antibody, respectively. Each antibody was used at 1:500 dilution in blocking buffer
Materials and methods
[4% milk powder and 0.2% Tween-20 in phosphate-buffered saline (PBS)] at room temperature for 1 h and immune complexes were Cell culture and colony assays detected by enhanced chemiluminescence (ECL) as described by the Normal human diploid fibroblasts, TIG-3 (Ohashi et al., 1980; obtained manufacturer (Amersham) . from the Japanese Cancer Research Resources Bank, Tokyo, Japan) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented Phosphate labelling and immunoprecipitation with 10% fetal bovine serum (FBS). The TIG-3 cells used in this study Asynchronously growing TIG-3 cells were made quiescent by placing were at relatively early passage, with estimated population doublings them in medium containing 0.2% fetal bovine serum for 4 days. Serum (PDs) of~30-35.
was then added to 20% (v/v) and at 2, 6, 10, 14, 16 and 22 h after For colony-forming assays, human U2OS osteosarcoma cells and serum addition, the cells were incubated with 0.5 mCi/ml of 32 P-labelled mouse NIH 3T3 cells, grown in DMEM plus 10% FBS, were seeded at orthophosphate for a further 2 h. The 32 P-labelled cells were washed 50% confluence in 100 mm dishes. The following day, duplicate plates with ice-cold PBS and lysates prepared in buffer (Ab buffer) containing were transfected with 10 μg of pcDNA3 (Invitrogen), pcDNA3-Id2-20 mM Tris-HCl pH 7.5, 50 mM NaCl, 0.5% NP-40, 0.5% SDS, 0.5% WT, or pcDNA3-Id2-S5A plasmid DNAs using the lipofectamine reagent deoxycholate, 1 mM EDTA and 100 μg of aprotinin/ml. Lysates were as described by the supplier (Gibco-BRL). After a further 24 h, the cells centrifuged at 15 000 r.p.m. for 30 min to remove debris and prewere split 1:15 in medium containing 350 μg of G418/ml. The medium cleared by addition of protein A/G beads (Pierce) for 1 h at 4°C. was changed every 4 days and after 16 days the cells were fixed and
Immunoprecipitations were performed with anti-Id2 antibody (SC-489) stained with Giemsa.
for 1 h at 4°C and the immune complexes recovered on protein A/G beads and washed four times with Ab buffer. The precipitated proteins Purification of bacterially expressed Id proteins were resuspended in sample buffer, boiled for 2 min and fractionated The human Id1 and Id2 coding sequences (Hara et al., 1994) were by SDS-PAGE on a 12% gel. cloned into the pGEX-T vector (Pharmacia) or the pRSET-B vector (Invitrogen) for expression in bacteria. The recombinant proteins were Two-dimensional phosphopeptide mapping expressed in Escherichia coli BL21(DE3)pLysS. GST-Id proteins were 32 P-Labelled Id2 protein, generated either by phosphorylation in vitro purified according to published protocols (Smith and Johnson, 1988) .
or by metabolic labelling, was purified by SDS-PAGE in a 12% gel and Histidine-tagged Id proteins produced in the pRSET-B vector were transferred onto a PVDF membrane. The membrane was exposed to purified on nickel-charged chelating agarose as recommended by the X-ray film to locate the Id2-specific bands. The relevant areas of the supplier (Invitrogen).
membrane were excised and subjected to trypsin digestion as described by Boyle et al. (1991) . The resultant peptides were separated on cellulose Electrophoretic mobility shift assays thin-layer plates by electrophoresis at pH 1.9 (10 min at 0.5 kV and Unlabelled proteins were synthesized by coupled transcription and 40 min at 1 kV) in the first dimension, with subsequent ascending translation of plasmid DNA using the TNT expression system (Promega) chromatography in the second dimension. The phosphopeptides were with either T7 or SP6 RNA polymerase. Samples (5 μl) of the different detected by autoradiography using Kodak X-AR 5 film at -80°C. translation reactions were mixed and used for DNA-binding assays. Whole-cell extracts were prepared from TIG-3 cells according to published procedures (Andrews and Faller, 1991) . and cyclin A antibodies, and members of the late H. Weintraub's Ephrussi,A., Church,G.M., Tonegawa,S. and Gilbert,W. (1985) 
